Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agilon Health (AGL) Cash from Operations (2020 - 2025)

Agilon Health (AGL) has disclosed Cash from Operations for 6 consecutive years, with 20537000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Operations fell 225.08% year-over-year to 20537000.0, compared with a TTM value of 105763000.0 through Dec 2025, down 83.05%, and an annual FY2025 reading of 105763000.0, down 83.05% over the prior year.
  • Cash from Operations was 20537000.0 for Q4 2025 at Agilon Health, down from 18154000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 16419000.0 in Q4 2024 and bottomed at 61166000.0 in Q4 2023.
  • Average Cash from Operations over 5 years is 29935300.0, with a median of 27610000.0 recorded in 2022.
  • The sharpest move saw Cash from Operations plummeted 591.8% in 2023, then soared 126.84% in 2024.
  • Year by year, Cash from Operations stood at 48897000.0 in 2021, then dropped by 2.17% to 49959000.0 in 2022, then fell by 22.43% to 61166000.0 in 2023, then skyrocketed by 126.84% to 16419000.0 in 2024, then tumbled by 225.08% to 20537000.0 in 2025.
  • Business Quant data shows Cash from Operations for AGL at 20537000.0 in Q4 2025, 18154000.0 in Q3 2025, and 35085000.0 in Q2 2025.